Role ofjoints hypermobility in diagnostics of syndromic forms of conjunctive tissue dysplasia and rheumatic disorders


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Hypermobility of the joints is a very common condition (from 6 to 57% in different populations), in which the amplitude of active and/ or passive movements in the joints exceeds the conventional average statistical rate. Hypermobility of the joints is one of the frequent manifestations of both undifferentiated and differentiated (syndromic) forms of connective tissue dysplasia. It can be a harbinger of systemic connective tissue diseases in combination with musculoskeletal pain syndrome.

Full Text

Restricted Access

About the authors

Inna A. Viktorova

FSBEI of Higher Education Omsk state medical university of the Ministry of Health of Russia

Email: ovpomsk@mail.ru
MD, professor, head of the Department of internal medicine and polyclinic therapy

Daria S. Ivanova

FSBEI of Higher Education Omsk state medical university of the Ministry of Health of Russia

Email: ovpomsk@mail.ru
MD, associate professor of the Department of internal medicine and polyclinic therapy

Nadezhda V. Konshu

FSBEI of Higher Education Omsk state medical university of the Ministry of Health of Russia

Email: nadias@mail.ru
PhD, assistant of the Department of internal medicine and polyclinic therapy

Maria V. Rozhina

Kabanov AN city clinical hospital № 1

General Practitioner of the Department of general practitioners No. 1

References

  1. Национальные рекомендации российского научного медицинского общества терапевтов по диагностике, лечению и реабилитации пациентов с дисплазиями соединительной ткани. Медицинский вестник Северного Кавказа. 2016. Т. 11. № 1. С. 2-76.
  2. Яковлев В.М., Нечаева Г.И., Мартынов А.И., Викторова И.А. Дисплазия соединительной ткани в практике врачей первичного звена здравоохранения: Руководство для врачей. М.: КСТ Интерфорум, 2016. 520 с.
  3. Celletti C. Evaluation of lower limb disability in joint hypermobility syndrome. Rheumatol. Int. 2012; 32 (8): 2577-81.
  4. Fikree А., Aziz Q., Grahame R. Joint Hypermobility Syndrome. Rheum. Dis. Clin. North Am. 2013; 39 (2): 419-30.
  5. Наследственные нарушения соединительной ткани: Российские рекомендации. М., 2012. 76 с.
  6. Коншу Н.В. Стратификация риска возникновения остеоартроза у пациентов с семейной гипермобильностью суставов. Врач-аспирант. 2015; 2.2 (69): 234-2.
  7. Викторова И.А., Киселева Д.С., Коншу Н.В. Диагностика гипермобильности суставов в амбулаторной практике. Российские медицинские вести. 2011. № 3. С. 76-83.
  8. Schomacher J. Hyper- und Hypomobile Gelenke - Tendenzen kennen. Physiopraxis. 2012; 10 (11): 1250-51.
  9. Grahame R., Hakim A.J. Arachnodactyly - a key to diagnosing heritable disorders of connective tissue. Nat. Rev. Rheumatol. 2013; 9 (6): 358-64.
  10. Voermans N.C., Knoop H. Both pain and fatigue are important possible determinants of disability in patients with the Ehlers-Danlos syndrome hypermobility type. Disabil. Rehabil. 2011; 33 (8): 706-07.
  11. Loeys B.L., Dietz H.C., Braverman A.C. The Revised Ghent Nosology for the Marfan Syndrome. J. Med. Genetics. 2010; 4: 476-85.
  12. Morgaron Y. Tenascin-X increases the stiffness of collagen gels without affecting fibrillogenesis. Biophysical chemistry. 2011; 147:87-91.
  13. Grahame R. Joint hypermobility syndrome pain. Curr Pain Headache Rep. 2012; 13: 427-33.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2018 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies